vs
Side-by-side financial comparison of Borealis Foods Inc. (BRLS) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.
Borealis Foods Inc. is the larger business by last-quarter revenue ($7.1M vs $4.9M, roughly 1.4× Sensus Healthcare, Inc.). Borealis Foods Inc. runs the higher net margin — -53.2% vs -64.1%, a 10.9% gap on every dollar of revenue. On growth, Borealis Foods Inc. posted the faster year-over-year revenue change (-12.0% vs -62.2%). Over the past eight quarters, Borealis Foods Inc.'s revenue compounded faster (-2.4% CAGR vs -31.9%).
Borealis Foods Inc is a food technology enterprise specializing in developing and producing high-quality plant-based protein products including plant-based meat alternatives. It mainly serves retail and food service customers across North America and Europe, focusing on delivering affordable, nutritious sustainable food options matching the taste of conventional animal-derived meat.
Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.
BRLS vs SRTS — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.1M | $4.9M |
| Net Profit | $-3.8M | $-3.2M |
| Gross Margin | 14.6% | 38.4% |
| Operating Margin | -27.1% | -63.8% |
| Net Margin | -53.2% | -64.1% |
| Revenue YoY | -12.0% | -62.2% |
| Net Profit YoY | 21.8% | -304.9% |
| EPS (diluted) | $-0.18 | $-0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $4.9M | ||
| Q3 25 | $7.1M | $6.9M | ||
| Q2 25 | $7.2M | $7.3M | ||
| Q1 25 | $6.8M | $8.3M | ||
| Q4 24 | $6.8M | $13.1M | ||
| Q3 24 | $8.1M | $8.8M | ||
| Q2 24 | $5.5M | $9.2M | ||
| Q1 24 | $7.9M | $10.7M |
| Q4 25 | — | $-3.2M | ||
| Q3 25 | $-3.8M | $-943.0K | ||
| Q2 25 | $-4.6M | $-1.0M | ||
| Q1 25 | $-4.2M | $-2.6M | ||
| Q4 24 | $-5.8M | $1.5M | ||
| Q3 24 | $-4.8M | $1.2M | ||
| Q2 24 | $-6.3M | $1.6M | ||
| Q1 24 | $-8.4M | $2.3M |
| Q4 25 | — | 38.4% | ||
| Q3 25 | 14.6% | 39.4% | ||
| Q2 25 | 7.2% | 39.7% | ||
| Q1 25 | 13.1% | 52.2% | ||
| Q4 24 | 3.7% | 54.4% | ||
| Q3 24 | 15.8% | 59.3% | ||
| Q2 24 | 7.7% | 58.7% | ||
| Q1 24 | 3.1% | 62.5% |
| Q4 25 | — | -63.8% | ||
| Q3 25 | -27.1% | -37.3% | ||
| Q2 25 | -46.7% | -26.6% | ||
| Q1 25 | -42.6% | -31.7% | ||
| Q4 24 | -68.4% | 13.2% | ||
| Q3 24 | -44.8% | 16.9% | ||
| Q2 24 | -94.8% | 21.5% | ||
| Q1 24 | -88.3% | 27.1% |
| Q4 25 | — | -64.1% | ||
| Q3 25 | -53.2% | -13.7% | ||
| Q2 25 | -64.0% | -14.2% | ||
| Q1 25 | -61.2% | -30.8% | ||
| Q4 24 | -85.3% | 11.8% | ||
| Q3 24 | -59.8% | 13.7% | ||
| Q2 24 | -115.0% | 17.4% | ||
| Q1 24 | -106.8% | 21.3% |
| Q4 25 | — | $-0.19 | ||
| Q3 25 | $-0.18 | $-0.06 | ||
| Q2 25 | $0.21 | $-0.06 | ||
| Q1 25 | $-0.20 | $-0.16 | ||
| Q4 24 | $-0.82 | $0.10 | ||
| Q3 24 | $-0.23 | $0.07 | ||
| Q2 24 | $0.29 | $0.10 | ||
| Q1 24 | $-0.49 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $22.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-12.9M | $48.1M |
| Total Assets | $56.3M | $53.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $22.1M | ||
| Q3 25 | — | $24.5M | ||
| Q2 25 | — | $22.2M | ||
| Q1 25 | — | $19.1M | ||
| Q4 24 | — | $22.1M | ||
| Q3 24 | — | $22.6M | ||
| Q2 24 | — | $19.0M | ||
| Q1 24 | — | $14.7M |
| Q4 25 | — | $48.1M | ||
| Q3 25 | $-12.9M | $51.2M | ||
| Q2 25 | $-9.2M | $52.1M | ||
| Q1 25 | $-4.8M | $53.0M | ||
| Q4 24 | $-695.9K | $55.8M | ||
| Q3 24 | $5.1M | $54.1M | ||
| Q2 24 | $9.9M | $52.9M | ||
| Q1 24 | $16.2M | $51.2M |
| Q4 25 | — | $53.0M | ||
| Q3 25 | $56.3M | $58.3M | ||
| Q2 25 | $57.3M | $58.9M | ||
| Q1 25 | $58.4M | $60.2M | ||
| Q4 24 | $60.0M | $62.2M | ||
| Q3 24 | $61.9M | $59.9M | ||
| Q2 24 | $63.6M | $58.2M | ||
| Q1 24 | $70.3M | $57.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-190.6K | $-2.2M |
| Free Cash FlowOCF − Capex | — | $-2.4M |
| FCF MarginFCF / Revenue | — | -47.9% |
| Capex IntensityCapex / Revenue | — | 3.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $332.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-2.2M | ||
| Q3 25 | $-190.6K | $2.3M | ||
| Q2 25 | $-2.2M | $3.1M | ||
| Q1 25 | $-1.4M | $-2.7M | ||
| Q4 24 | $-819.4K | $-827.0K | ||
| Q3 24 | $-3.3M | $4.0M | ||
| Q2 24 | $-4.2M | $4.2M | ||
| Q1 24 | $-6.8M | $-8.2M |
| Q4 25 | — | $-2.4M | ||
| Q3 25 | — | $2.3M | ||
| Q2 25 | — | $3.1M | ||
| Q1 25 | $-1.4M | $-2.7M | ||
| Q4 24 | $-951.6K | $-1.1M | ||
| Q3 24 | $-3.7M | $3.6M | ||
| Q2 24 | $-4.7M | $4.2M | ||
| Q1 24 | $-7.3M | $-8.4M |
| Q4 25 | — | -47.9% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 42.2% | ||
| Q1 25 | -20.3% | -32.2% | ||
| Q4 24 | -14.1% | -8.6% | ||
| Q3 24 | -46.1% | 40.9% | ||
| Q2 24 | -86.7% | 45.8% | ||
| Q1 24 | -92.7% | -79.0% |
| Q4 25 | — | 3.2% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | 0.2% | 0.1% | ||
| Q4 24 | 2.0% | 2.3% | ||
| Q3 24 | 5.6% | 3.8% | ||
| Q2 24 | 9.4% | 0.0% | ||
| Q1 24 | 7.0% | 2.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.53× | ||
| Q3 24 | — | 3.25× | ||
| Q2 24 | — | 2.62× | ||
| Q1 24 | — | -3.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BRLS
Segment breakdown not available.
SRTS
| Products | $2.8M | 57% |
| Other | $2.1M | 43% |
